Myles Paul S, Hunt Jennifer O, Fletcher Helen, Watts Jennifer, Bain David, Silvers Andrew, Buckland Mark R
Department of Anaesthesia & Pain Management, Alfred Hospital, Prahran, Victoria, Australia.
Anesth Analg. 2002 Oct;95(4):805-12, table of contents. doi: 10.1097/00000539-200210000-00004.
Remifentanil may be beneficial in patients undergoing coronary artery bypass graft surgery, by promoting hemodynamic stability, reducing drug requirements, and attenuating the neurohumoral "stress response." We enrolled 77 cardiac surgical patients in a double-blinded, randomized trial and randomly allocated them to one of three groups: remifentanil infusion at 0.83 micro g. kg(-1). min(-1) (Group R); fentanyl bolus, small dose, at 12 micro g/kg (Group FLD); and fentanyl bolus, moderate dose, at 24 micro g/kg (Group FMD). We found a significant difference in the median time to tracheal extubation: Group FLD, 6.5 h; Group R, 7.3 h; and Group FMD, 9.7 h (P = 0.025). Group R patients had similar times to those of Groups FLD (P = 0.14) and FMD (P = 0.30). Group FLD patients had a longer length of hospital stay (P = 0.030). Patients in Group R had a significantly infrequent rate of hypertension but a frequent rate of hypotension (P < 0.01). The urinary cortisol excretion was larger in Group FLD patients (P < 0.0005), and urine flow was smaller (P < 0.0005). Remifentanil was associated with a propofol dose reduction (P = 0.0005) and a concomitant higher bispectral index (P = 0.032). Three Group FLD patients, but none in groups FMD and R, had postoperative myocardial infarctions (P = 0.032). Remifentanil has larger drug acquisition costs but does not increase the total hospital costs associated with cardiac surgery.
Remifentanil did not significantly reduce the duration of tracheal intubation after cardiac surgery. Remifentanil, when compared with fentanyl (total doses of approximately 15 and 28 micro g/kg), blunts the hypertensive responses associated with cardiac surgery but is associated with more hypotension; when compared with fentanyl 15 micro g/kg, remifentanil reduces cortisol excretion. Larger-dose opioids (remifentanil 0.85 micro g. kg(-1). min(-1) or fentanyl 28 micro g/kg) were associated with a decreased rate of myocardial infarction after cardiac surgery.
瑞芬太尼可能对接受冠状动脉搭桥手术的患者有益,可促进血流动力学稳定、减少药物需求并减轻神经体液“应激反应”。我们将77例心脏手术患者纳入一项双盲随机试验,并将他们随机分为三组之一:以0.83μg·kg⁻¹·min⁻¹的速度输注瑞芬太尼(R组);小剂量芬太尼推注,剂量为12μg/kg(FLD组);中等剂量芬太尼推注,剂量为24μg/kg(FMD组)。我们发现气管拔管的中位时间存在显著差异:FLD组为6.5小时;R组为7.3小时;FMD组为9.7小时(P = 0.025)。R组患者的时间与FLD组(P = 0.14)和FMD组(P = 0.30)相似。FLD组患者的住院时间更长(P = 0.030)。R组患者高血压发生率显著较低,但低血压发生率较高(P < 0.01)。FLD组患者尿皮质醇排泄量更大(P < 0.0005),尿量更小(P < 0.0005)。瑞芬太尼与丙泊酚剂量减少相关(P = 0.0005),同时脑电双频指数更高(P = 0.032)。FLD组有3例患者发生术后心肌梗死,而FMD组和R组均无(P = 0.032)。瑞芬太尼的药物购置成本更高,但不会增加心脏手术相关的总住院费用。
瑞芬太尼并未显著缩短心脏手术后气管插管的持续时间。与芬太尼(总剂量约为15和28μg/kg)相比,瑞芬太尼可减轻与心脏手术相关的高血压反应,但会导致更多低血压;与15μg/kg芬太尼相比,瑞芬太尼可减少皮质醇排泄。大剂量阿片类药物(瑞芬太尼0.85μg·kg⁻¹·min⁻¹或芬太尼28μg/kg)与心脏手术后心肌梗死发生率降低相关。